Synteza nowego koniugatu nanocząsteczek magnetycznych z nanopęcherzykami perfluorowęglowodoru jako potencjalnej terapii wspomagającej w ostrym niedokrwieniu mięśnia sercowego by Arokiaraj, Mark C.
425www.journals.viamedica.pl/folia_cardiologica
Folia Cardiologica 2019 
tom 14, nr 4, strony 425–427 
DOI: 10.5603/FC.a2018.0095 
Copyright © 2019 Via Medica
ISSN 2353–7752
SPRAWOZDANIE
Address for correspondence: Professor Mark C. Arokiaraj, Pondicherry Institute of Medical Sciences, Kalapet, 605014 Pondicherry, India,  
e-mail: christomark@gmail.com
Novel synthesis of magnetic nanoparticles conjugation  
with perfluorocarbon nanobubbles for potential  
adjunct therapy of acute myocardial ischaemia
Synteza nowego koniugatu nanocząsteczek magnetycznych  
z nanopęcherzykami perfluorowęglowodoru jako potencjalnej  
terapii wspomagającej w ostrym niedokrwieniu mięśnia sercowego
Mark C. Arokiaraj●iD
Pondicherry Institute of Medical Sciences, Pondicherry, India
Abstract
Introduction. This study was performed in search of a novel adjunct agent for myocardial salvage in acute myocardial 
ischaemia.
Methods and results. This is a report of conjugation between perfluorocarbon nanobubbles with multifunctional bio-
compatible magnetic nanoparticles. It was possible to synthesise the conjugation of multifunctional biocompatible 
magnetic nanoparticles with perfluorocarbon nanobubbles. The potential nano-size magnetic product could cross the 
deranged endothelial borders in the ischaemic penumbra regions, and could help in myocardial salvage. Furthermore, 
the particles could be focused to the target region using the magnetic micromesh technique.
Conclusions. A conjugation between magnetic nanoparticles and PFC nano-bubbles is possible. Further studies need 
to be performed to explore the potential uses.
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Introduction
Perfluorocarbons (PFC) are known to have a high affinity 
for oxygen, and they are useful as oxygen carriers. The 
combination of perfluorocarbons with magnetic nano-
particles would be useful to penetrate endothelium and 
supply oxygen because of their size. The potential aim of 
this study was to prepare this conjugate and analyse its 
basic characteristics. This could help in myocardial salvage 
or reduced infarct size, which is potentially very useful.
Methods and results
Perfluorocarbon nanobubbles were prepared using stan-
dard techniques [1]. PFC nanobubbles-magnetic nano-
particle conjugation was performed, and the final solution 
prepared had a pH of 8.0. The conjugation was performed 
to form covalent bonding and phosphate buffered saline 
(PBS) buffer was used. The final preparation was an emul-
sion with a PFC content of 25% and 40% concentration in 
each emulsion of 300 μL. The final volume achieved in the 
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concentration was 15 mg/mL and the particle concentra-
tion in 300 μL was 4.5 mg. A drop of emulsion subjected 
to the magnetic field by a small magnet tends to polarise 
to one side due to the effect of the magnetic field. These 
particles are easy and respond quickly to the magnetic field. 
On a glass slide when allowed to dry the conjugate forms 
a thick film like a mountain, and when a small amount of 
water is added and a small magnet is applied nearby, the 
particles start moving towards the magnet.
A drop of the emulsion can be diluted with water or dilu-
ted podium dodecyl sulfate (SDS) solution, and the particle 
sizes can be measured by dynamic light scattering. The 
particle sizes were estimated by dynamic light scattering, and 
the magnetic nanoparticles were of 100 to 200 nm, and they 
were magnetically active, which has been proven in other 
studies [2–4]. These nanoparticles were multifunctional 
and highly biocompatible, again as demonstrated in other 
studies. A previous study showed the generation of high mag-
netic gradients using mesh, and through these remarkably 
high gradients, the magnetic nanoparticles movements co-
uld be controlled [4]. Using this, previous studies have shown 
that these particles can be activated on selected targets for 
effective drug delivery [1–4]. In ischaemic regions, oxygen 
could be delivered using the magnetic grid and magnetically 
conjugated particles. In myocardial infarction, the coronaries 
are like end arteries, and they are cutoff by the arterial occlu-
sion. Hence, these nanoparticles can reach the penumbra 
of the infarct through their neighbouring blood vessels or 
branches, and they could deliver oxygen and thereby could 
have the potential to reduce infarct size [5]. Ultrasonication 
of these multifunctional particles is feasible, and they can be 
activated by ultrasound [6–8]. Potential further improvised 
conjugation with tripeptide Arg-Gly-Asp (RGD) and other bio-
-molecules is feasible. However, a simple oxygen gradient 
in ischaemic tissues is good enough to release oxygen from 
the nanodroplets. Perfluorocarbon nanobubbles have shown 
to prevent injury in ardiomyocytes subjected to hypoxia [9]. 
This is the first known synthesis of these magnetic 
nanoparticles with perfluorocarbon nanodroplets conjuga-
tion. However, further experiments are required to study 
its properties in greater detail. Also, physical evaluation 
with X-ray diffraction crystallography and scanning elec-
tron microscopy observations are required. This is the first 
preparation, and further evaluation with a large sample 
volume is required for the next phase. The samples could 
be estimated by tissue culture in Matrigel in various con-
centrations to evaluate their tissue penetration and oxygen 
delivery properties under magnetic fields.
Conclusions
A conjugation between magnetic nanoparticles and PFC 
nano-bubbles is possible. Further studies need to be per-
formed to explore the potential uses.
Figure 1. Photo image under microscope of the perfluorocarbons 
(PFC) nanobubble — magnetic nanoparticle conjugate emulsion
synthesis was 300 μL of each concentration, and the final 
compound was stable. The final sample when evaluated 
under microscope gave an image shown in Figure 1. The 
polydispersity index was < 0.25. The magnetic nanoparticle 
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Streszczenie
Wstęp. Celem badania było poszukiwanie nowych leków wspomagających zachowanie żywotności miokardium po ostrym 
niedokrwieniu mięśnia sercowego.
Metody i wyniki. W niniejszej pracy opisano koniugację nanopęcherzyków perfluorowęglowodoru z biokompatybilnymi 
wielofunkcyjnymi nanocząsteczkami magnetycznymi. Okazało się, że możliwa jest synteza koniugatu wielofunkcyjnych 
biokompatybilnych cząstek magnetycznych z nanopęcherzykami perfluorowęglowodoru. Otrzymane w ten sposób nano-
cząsteczki magnetyczne mogą przenikać przez uszkodzony śródbłonek w regionie otaczającym obszar zawału i mogłyby 
zostać wykorzystane do ratowania mięśnia sercowego przed trwałym uszkodzeniem. Ponadto cząsteczki te można 
doprowadzić do docelowego miejsca, stosując technikę mikrosiatki magnetycznej.
Wnioski. Koniugacja między nanocząsteczkami magnetycznymi a nanopęcherzykami perfluorowęglowodoru jest możli-
wa. Należy przeprowadzić dalsze badania nad możliwościami ich wykorzystania.
Słowa kluczowe: ostry zawał serca, leczenie farmakologiczne, nauki podstawowe, hipoksja
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